Get email alerts on the Plan Design topic
No spam. Unsubscribe anytime.
Plan Design Committee to implement Virta prescribing program, keeps dental unchanged
Summary
The commission’s Plan Design Committee agreed to implement Virta’s Responsible Prescribing Program to pursue cost savings and to assist member transitions off GLP‑1 medications; members also agreed to make no changes to the dental plan as renewal projections fell from 12.3% to 9.6%.
The State Employee Health Commission’s Plan Design Committee reported on Feb. 19 that it will implement Virta’s Responsible Prescribing Program as part of plan design recommendations aimed at regulating glucagon‑like peptide‑1 (GLP‑1) medications and achieving cost savings.
Committee materials show the renewal projection declined from 12.3% to 9.6%, and staff said the committee agreed to pursue Virta’s program "because of cost savings and regulation of glucagon‑like peptide‑1 (GLP‑1s) by assisting members in transitioning off these medications." The committee also agreed to make no changes to the dental plan.
AI generated
The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.
AI can make mistakes, so if you spot one, and we will fix it for everyone.
Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.
